Redmile Group’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-370,839
Closed -$938K 86
2023
Q4
$938K Sell
370,839
-28,600
-7% -$66.6K 0.03% 64
2023
Q3
$955K Sell
399,439
-1,471,400
-79% -$3.26M 0.05% 63
2023
Q2
$4.32M Hold
1,870,839
0.17% 60
2023
Q1
$4.77M Buy
1,870,839
+370,839
+25% +$1.06M 0.21% 60
2022
Q4
$3.77M Sell
1,500,000
-370,839
-20% -$1.03M 0.15% 55
2022
Q3
$5.42M Sell
1,870,839
-217,800
-10% -$917K 0.21% 60
2022
Q2
$9.44M Sell
2,088,639
-1,818,131
-47% -$10.8M 0.36% 49
2022
Q1
$31.3M Sell
3,906,770
-236,000
-6% -$2.08M 0.98% 29
2021
Q4
$48.2M Buy
4,142,770
+170,500
+4% +$2.04M 1.1% 28
2021
Q3
$49.2M Buy
+3,972,270
New +$44.8M 0.86% 37

Redmile Group's SLGC Position: Q1 2024 in Review

Redmile Group sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 370,839 shares — an estimated $938K sold.

Redmile Group first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $49.2M in Q3 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Redmile Group reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Redmile Group sold 370,839 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $938K.
  • Redmile Group first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Redmile Group's SomaLogic, Inc. Class A Common Stock position peaked at $49.2M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Redmile Group's 13F filing for Q1 2024, filed 15 May 2024.